Quay Pharma

Activities: Packaging Regulatory Research & Development Cleaning

Trending Articles

  1. Medac and chiron develop organ-on chip tech for animal free drug testing The companies aim to develop an animal-free pharmaceutical testing method that utilises organ-on chip technology, and will be used in rheumatoid arthritis drug testing
  2. Lonza expands bioconjugation capabilities for ADC manufacturing at Visp site The CDMO's facility will double its bioconjugate manufacturing capacity with two 1,200 L manufacturing suites
  3. Ascend Advanced Therapies expands US footprint through Advanced BioScience Laboratories merger Ascend's collaboration with EW Healthcare partners will expand its reach in the US pharmaceutical market through capital investment and an uptick in GMP AAV manufacturing capacity
  4. IMed supports K2 medical systems in their EU MDR transition Consultancy firm helps K2 navigate the complex regulatory process to achieve Article 97 compliance
  5. Rousselot and IamFluidics launch dissolvable microcarrier for cell culturing The alginate and denatured collagen based product allows researchers to produce scalable cell cultures for biologic drugs and cell therapies

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

Related Content

Drug Delivery

SGS Quay Pharma receives Queen’s Award for industry

Leading pharmaceutical contract development and manufacturing organisation (CDMO) SGS Quay Pharma has received its Queen’s Award for Enterprise
Finance

SGS makes full-service CDMO acquisition

The investment from SGS is hoped to enhance the development of the company’s work in live biotherapeutics, and its expansion in the United States
Drug Delivery

Quay Pharma partners with XenoGesis on drug development

The partnership aims to accelerate the drug development process for both companies’ clients
Analysis

Advanced equipment enables checking of herbal claims

Quay Pharma is using a Waters UPLC system to provide vital analysis for herbal supplements
Drug Delivery

Drug delivery solution for the treatment of gastrointestinal disorders

Quay Pharma has developed a specialised filling system to enable a new treatment for anorectal diseases to enter Phase III clinical trials
Regulatory

Quay establishes biotherapeutic GMP suites

The UK based pharmaceutical outsourcing specialist continues to invest in its work in live biotherapeutics at its facility in Deeside, Flintshire, UK
Research & Development

Quay Pharma to supply promising cancer drug for trial

Quay Pharma has reached an agreement with Redx Pharma to manufacture Redx’s breakthrough cancer treatment drug
Subscribe now